Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis
Trial details
- Registry ID
- NCT04598269
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic DermatitisNCT04598269 | ACRS | Phase 2 | Completed | 2021-04-08Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |